Stemtech Corp (STEK) is a direct-sales nutritional supplement company that markets patented, plant-based botanical products designed to support adult stem cell release, circulation, and migration in the human body. Revenue comes from product sales through a network of independent business partners (IBPs) who sell the company's formulations to end consumers. Net sales were $5,053,690 for the fiscal year ended December 31, 2024, up from $4,921,531 in FY2023, with the increase attributed to growth in the IBP distributor base. Total operating expenses for FY2024 were $6,113,773, meaning the company operated at a loss for the period. The 10-K filed June 30, 2025 includes a going-concern disclosure, and management has stated it expects to require additional capital raised through equity or debt securities. CEO is Charles S. Arnold; President and COO is John W. Meyer. Products include the RCM System stem cell nutrition formulations and the OraStem toothpaste line. The company's securities are classified as penny stocks.

Revenue model

Transactional product sales through a network of independent business partners (IBPs); net sales of $5,053,690 in FY2024 (fiscal year ended December 31, 2024).

Products and services

RCM System: patented, plant-based botanical supplement formulations intended to support stem cell release, circulation, and migration. OraStem toothpaste: all-natural tooth whitener and breath freshener. Products do not contain stem cells.

Customers and end markets

End consumers purchasing through IBP distributors; health and wellness supplement buyers. No customer concentration data disclosed in the excerpts.

Value-chain role

Product developer and manufacturer of proprietary botanical supplement formulations sold through a multi-level or direct-sales IBP distribution network.

Geographic exposure

Operations include subsidiaries; foreign currency translation adjustments referenced in financial statements, indicating some international operations, but specific countries or revenue by geography are not disclosed in the excerpts.

Source: SEC 10-K, filed 2025-06-30

Industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries